Expression of tight junction transmembrane protein Claudin-1 in gastric carcinoma and effects on tumor cell proliferation, invasion and migration

1. Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, et al. Gastric cancer as preventable disease. Clin Gastroenterol Hepatol. 2017;15(12):1833-43. DOI: 10.1016/j.cgh.2017.05.02310.1016/j.cgh.2017.05.02328532700Search in Google Scholar

2. Tsukita S, Tanaka H, Tamura A. The claudins: from tight junctions to biological systems. Trends Biochem Sci. 2019;44(2):141-52. DOI: 10.1016/j.tibs.2018.09.00810.1016/j.tibs.2018.09.00830665499Search in Google Scholar

3. Che J, Yang Y, Xiao J, Zhao P, Yan B, Dong S, et al. Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma. Tumour Biol. 2015;36(8):6559-68. DOI: 10.1007/s13277-015-3350-110.1007/s13277-015-3350-125820701Search in Google Scholar

4. Moldvay J, Fábián K, Jäckel M, Németh Z, Bogos K, Furák J, et al. Claudin-1 protein expression is a good prognostic factor in non-small cell lung cancer, but only in squamous cell carcinoma cases. Pathol Oncol Res. 2017;23(1):151-6. DOI: 10.1007/s12253-016-0115-010.1007/s12253-016-0115-027687058Search in Google Scholar

5. Liu M, Yang J, Zhang Y, Zhou Z, Cui X, Zhang L, et al. ZIP4 promotes pancreatic cancer progression by repressing ZO-1 and Claudin-1 through a ZEB1-dependent transcriptional mechanism. Clin Cancer Res. 2018;24(13):3186-96. DOI: 10.1158/1078-0432.CCR-18-026310.1158/1078-0432.CCR-18-0263700604829615456Search in Google Scholar

6. Majer A, Blanchard AA, Medina S, Booth SA, Myal Y. Claudin 1 expression levels affect miRNA dynamics in human basal-like breast cancer cells. DNA Cell Biol. 2016;35(7):328-39. DOI: 10.1089/dna.2015.318810.1089/dna.2015.318826982264Search in Google Scholar

7. Masterson JC, Biette KA, Hammer JA, Nguyen N, Capocelli KE, Saeedi BJ, et al. Epithelial HIF-1 α/claudin-1 axis regulates barrier dysfunction in eosinophilic esophagitis. J Clin Invest. 2019;129(8):3224-35. DOI: 10.1172/JCI12674410.1172/JCI126744666867031264974Search in Google Scholar

8. Suh Y, Yoon CH, Kim RK, Lim EJ, Oh YS, Hwang SG, et al. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells. Oncogene. 2013;32(41):4873-82. DOI: 10.1038/onc.2012.50510.1038/onc.2012.50523160379Search in Google Scholar

9. Kozak J, Forma A, Czeczelewski M, Kozyra P, Sitarz E, Radzikowska-Büchner E, et al. Inhibition or reversal of the epithelial-mesenchymal transition in gastric cancer: pharmacological approaches. Int J Mol Sci. 2021;22(1):277. DOI: 10.3390/ijms2201027710.3390/ijms22010277779501233383973Search in Google Scholar

10. Tabariès S and Siegel PM. The role of claudins in cancer metastasis. Oncogene. 2017;36(9):1176-90. DOI: 10.1038/onc.2016.28910.1038/onc.2016.28927524421Search in Google Scholar

11. Zhou B, Moodie A, Blanchard AA, Leygue E, Myal Y. Claudin 1 in Breast Cancer: New Insights. J Clin Med. 2015;4(12):1960-76. DOI: 10.3390/jcm412195210.3390/jcm4121952469315226633531Search in Google Scholar

12. Ouban A. Claudin-1 role in colon cancer: An update and a review. Histol Histopathol. 2018;33(10):1013-9.Search in Google Scholar

13. Nam KH, Yoon H, Lee K, Park DJ, Kim HH, Lee HS, et al. Predictive value for lymph node metastasis of epithelial-mesenchymal transition and cancer stem cell marker expression in early gastric cancer. Pathol Res Pract. 2017;213(9):1221-6. DOI: 10.1016/j.prp.2017.03.01010.1016/j.prp.2017.03.01028595915Search in Google Scholar

14. Wang H, Yang X. The expression patterns of tight junction protein claudin-1, -3, and -4 in human gastric neoplasms and adjacent non-neoplastic tissues. Int J Clin Exp Pathol. 2015;8(1):881-7.Search in Google Scholar

15. Hämäläinen L, Soini Y, Pasonen-Seppänen S, Siponen M. Alterations in the expression of EMT-related proteins claudin-1, claudin-4 and claudin-7, E-cadherin, TWIST1 and ZEB1 in oral lichen planus. J Oral Pathol Med. 2019;48(8):735-44. DOI: 10.1111/jop.1291710.1111/jop.1291731228209Search in Google Scholar

16. Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer. 2018;18(2):128-34. DOI: 10.1038/nrc.2017.11810.1038/nrc.2017.11829326430Search in Google Scholar

17. Deng M, Zhang Y, Liu B, Chen Y, Song H, Yu R, et al. β-Elemene inhibits peritoneal metastasis of gastric cancer cells by modulating FAK/Claudin-1 signaling. Phytother Res. 2019;33(9):2448-56. DOI: 10.1002/ptr.643610.1002/ptr.643631342604Search in Google Scholar

18. Izraely S, Sagi-Assif O, Klein A, Meshel T, Ben-Menachem S, Zaritsky A, et al. The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis. Int J Cancer. 2015;136(6):1296-307. DOI: 10.1002/ijc.2909010.1002/ijc.2909025046141Search in Google Scholar